| Application no. and date | 03793791.9 (espacenet) (Federated) (European Patent Register), 20030903 | | Patent/reg. no. and date | DK/EP 1537104, 20091111 | | Publication date | 20050608 | | Priority no. and date | GB 0220581, 20020904 | | EP pub. no. and date |
EP 1537104 20050608 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 137877 | | Inventor | FEUERBACH, Dominik, Wehrgasse 3
79379 Müllheim, DE,
HURTH, Konstanze, 4, rue de l'Ancien Golf
68300 Saint Louis, FR,
RITCHIE, Timothy John
Novartis Inst. Med. Sc., University College,
5 Gower Place
London WC1E 6BS, GB,
BOUHELAL, Rochdi, Novartis Pharma AG,
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 31/439 (2006.01) , A61P 25/28 (2006.01) , C07D 453/02 (2006.01) , C07D 487/08 (2006.01) | | Title | Azabicycloalkylethere og deres anvendelse som alfa7-nAChR-agonister | | Int. application no. | EP2003009772 | | Int. publication no. | WO2004022556 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
